ולוויר

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

VALACICLOVIR AS HYDROCHLORIDE 500 MG

Disponible desde:

RAFA LABORATORIES LTD

Código ATC:

J05AB11

formulario farmacéutico:

FILM COATED TABLETS

Vía de administración:

PER OS

Fabricado por:

PHARMATHEN S.A., GREECE

Grupo terapéutico:

VALACICLOVIR

indicaciones terapéuticas:

Valovir is indicated for the treatment of herpes zoster (shingles) in immunocopotent adults. Valovir accelerates the resolution of pain, it reduces the duration, and the proportion of patients with zoster-associated pain, which includes acute and post-herpetic neuralgia. The efficacy of valaciclovir in immunocompromised patients has not been established.Valovir is indicated for the treatment of the initial and recurrent genital herpes due to herpes simplex infection. Valovir is indicated for the prevention (suppression) of recurrent herpes simplex infections (herpes genitalis). Prophylaxis of cytomegalovirus infection and disease, following organ transplantation. For the treatment of cold sores (herpes labialis).

Fecha de autorización:

2013-05-01